Please use this identifier to cite or link to this item:
|標題:||Unique microRNA signature and clinical outcome of cancers||作者:||Yu, S.L.
|關鍵字:||angiotensin-ii type-1;cell lung-cancer;chronic lymphocytic-leukemia;down-regulation;breast-cancer;c-myc;expression;gene;rna;targets||Project:||DNA and Cell Biology||期刊/報告no：:||DNA and Cell Biology, Volume 26, Issue 5, Page(s) 283-292.||摘要:||
MicroRNAs (miRNAs) are endogenous small non-protein-coding RNAs (18-25 nucleotides) that conduct the post-transcriptional repression of hundreds of their target proteins. They regulate many kinds of basic cellular processes including proliferation, differentiation, stress response, and cell death. Recent evidence has shown that deregulation of miRNAs correlates with certain features of diverse cancers ( such as tumorigenesis, differentiation status, and outcome of tumor patients), and indicates that miRNAs can act as oncogenes or tumor suppressors. Here, we summarize these recent studies and provide a new perspective on understanding the role of miRNAs in initiation and progression of cancers. We also discuss the future applications of miRNAs in diagnostic and prognostic implications of cancers.
|Appears in Collections:||生物醫學研究所|
Show full item record
TAIR Related Article
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.